Molecular endoscopic ultrasound for diagnosis of pancreatic cancer

Cancers

Volumn 3, Issue 1, 2011, Pages 872-882

  Bournet, Barbara ^a   Pointreau, Adeline ^a   Delpu, Yannick ^a   Selves, Janick ^a   Torrisani, Jerome ^a   Buscail, Louis ^a   Cordelier, Pierre ^a  

^a CHU RANGUEIL   (France)

Author keywords

Chronic pancreatitis; Endoscopic ultrasound guided fine needle aspiration biopsy; KRAS oncogene; MicroRNA; Pancreatic ductal adenocarcinoma

Indexed keywords

CYTIDINE DEAMINASE; DEOXYCYTIDINE KINASE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GEMCITABINE; MESSENGER RNA; MICRORNA; RIBONUCLEOTIDE REDUCTASE;

ASPIRATION BIOPSY; CAPILLARY ELECTROPHORESIS; CHRONIC PANCREATITIS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOLOGY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DNA EXTRACTION; DRUG SENSITIVITY; DRUG TARGETING; EGFR GENE; EGR GENE; ENDOSCOPIC ECHOGRAPHY; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LCN2 GENE; MOLECULAR IMAGING; MUTATIONAL ANALYSIS; ONCOGENE; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PERFORMANCE MEASUREMENT SYSTEM; PLAT GENE; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

EID: 79953693013     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3010872     Document Type: Review

References (42)

1. Warshaw, A.L.; Fernandez-del-Castillo, C. Pancreatic carcinoma. N. Eng. J. Med. 1992, 326, 455-465.
2. Buscail, L.; Pagès, P.; Berthelémy, P.; Fourtanier, G.; Frexinos, J.; Escourrou J. Role of EUS in the management of pancreatic and ampullary carcinoma: A prospective study assessing resectability and prognosis. Gastrointest. Endosc. 1999, 50, 34-4.
3. Burris, H.A., 3rd; Moore, M.J.; Andersen, J.; Green, M.R.; Rothenberg, M.L.; Modiano, M.R.; Cripps, M.C.; Portenoy, R.K.; Storniolo, A.M.; Tarassoff, P.; Nelson, R.; Dorr, F.A.; Stephens, C.D.; Von Hoff, D.D. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 1997, 15, 2403-2413.
4. Ducreux, M; Boige, V; Malka, D. Treatment of advanced pancreatic cancer. Semin. Oncol. 2007, 34, S25-S30.
5. Conroy, T.; Desseigne, F.; Ychou, M.; Ducreux, M.; Bouche, O.; Guimbaud, R.; Becouarn, Y.; Montoto-Grillot, C.; Gourgou-Bourgade, S.; Adenis, A.; FNCLCC-FFCD PRODIGE Group. Randomized phase III trial comparing FOLFIRINOX (F: 5FU/leucovorin, irinotecan, and oxaliplatin) versus gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): Preplanned interim analysis results of the PRODIGE 4/ACCORD 11 trial. J. Clin. Oncol. 2010, 28, suppl., Abstr. 4010.
6. Varadarajulu, S.; Tamhane, A.; Eloubeidi, M.A. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest. Endosc. 2005, 62, 728-736.
7. Fritscher-Ravens, A.; Brand, L.; Knöfel, W.T.; Knöfel, W.T.; Bobrowski, C.; Topalidis, T.; Thonke, F.; de Werth, A.; Soehendra, N. Comparison of endoscopic ultrasound-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis. Am. J. Gastroenterol. 2002, 97, 2768-2775.
8. Hawes, R.H. Endoscopic ultrasound. Gastrointest. Endosc. Clin. N. Am. 2000, 10, 161-74.
9. Buscail, L.; Faure, P.; Bournet, B.; Selves, J.; Escourrou, J. Interventional endoscopic ultrasound in pancreaticdiseases. Pancreatology 2006, 6, 7-16.
10. Wiersema, M.J. Accuracy of endoscopic ultrasound in diagnosing and staging pancreatic carcinoma. Pancreatology 2001, 1, 625-632.
11. Bhutani, M.S.; Logroño, R. Endoscopic ultrasound-guided fine-needle aspiration cytology for diagnosis above and below the diaphragm. J. Clin. Ultrasound 2005, 33, 401-411.
12. Bournet, B.; Migueres, I.; Delacroix, M.; Vigouroux, D.; Bornet, J.L.; Escourrou, J.; Buscail, L. Early morbidity of endoscopic ultrasound: 13 years' experience at a referral center. Endoscopy 2006, 38, 349-354.
13. Savides, T.J.; Donohue, M.; Hunt, G.; Al-Haddad, M.; Aslanian, H.; Ben-Menachem, T.; Chen, V.K.; Coyle, W.; Deutsch, J.; DeWitt, J.; Dhawan, M.; Eckardt, A.; Eloubeidi, M.; Esker, A.; Gordon, S.R.; Gress, F.; Ikenberry, S.; Joyce, A.M.; Klapman, J.; Lo, S.; Maluf-Filho, F.; Nickl, N.; Singh, V.; Wills, J.; Behling C. EUS-guided FNA diagnostic yield of malignancy in solid pancreatic masses: A benchmark for quality performance measurement. Gastrointest. Endosc. 2007, 66, 277-282.
14. Khalid, A. Differentiating neoplastic benign lesion of the pancreas: Translational techniques. Clin. Gastroenterol. Hepatol. 2009, 7, S55-S58.
15. Bournet, B.; Souque, A.; Senesse, P.; Assenat, E.; Barthet, M.; Lesavre, N.; Aubert, A.; O'Toole, D.; Hammel, P.; Levy, P.; Ruszniewski, P.; Bouisson, M.; Escourrou, J.; Cordelier, P.; Buscail, L. EUS-guided fine needle-aspiration biopsy coupled to KRAS mutation assay to differentiate pancreatic cancer from pseudo-tumorous chronic pancreatitis. Endoscopy 2009, 41, 552-557.
16. Van Laethem, J.L.; Vertongen, P, Deviere, J.; Van Rampelbergh, J.; Rickaert, F.; Cremer, M.; Robberecht, P. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Gut 1995, 36, 781-787.
17. Berthélemy, P.; Bouisson, M.; Escourrou, J.; Vaysse, N.; Rumeau, J.L.; Pradayrol, L. Identification of KRAS mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann. Intern. Med. 1995, 123, 188-191.
18. Costentin, L; Pagès, P; Bouisson, M.; Berthelémy, P.; Buscail, L.; Escourrou, J.; Pradayrol, L.; Vaysse, N. Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases. Pancreatology 2002, 2, 17-25.
19. Hahn, S.A.; Schmiegel, W.H. Recent discoveries in cancer genetics of exocrine pancreatic neoplasia. Digestion 1998, 59, 493-501.
20. Koorstra, J.B.M.; Hustinx, S.R.; Offerhaus, G.J.A.; Maitra, A. Pancreatic carcinogenesis. Pancreatology 2008, 8, 110-125.
21. Löhr, M.; Klöppel, G.; Maisonneuve, P.; Lowenfels, A.B.; Lüttges, J. Frequency of KRAS mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: A meta-analysis. Neoplasia 2005, 7, 17-723.
22. Tada, M.; Komatsu, Y.; Kawabe, T.; Sasahira, N.; Isayama, H.; Toda, N.; Shiratori, Y.; Omata, M. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am. J. Gastroenterol. 2002, 97, 2263-2270.
23. Pellisé, M.; Castells, A.; Ginès, A.; Solé, M.; Mora, J.; Castellvi-Bel, S.; Rodriguez-Moranta, F.; Fernandez-Esparrach, G.; Llach, J.; Bordas, JM.; Navarro, S.; Piqué, JM. Clinical usefulness of KRAS mutational analysis in the diagnosis of pancreatic adenocarcinoma by means of endosonography-guided fine-needle aspiration biopsy. Aliment. Pharmacol. Ther. 2003, 17, 1299-1307.
24. Takahashi, K.; Yamao, K.; Okubo, K.; Sawaki, A.; Mizuno, N.; Ashida, R.; Koshikawa, T.; Ueyama, Y.; Kasugai, K.; Hase, S.; Kakumu, S. Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA. Gastrointest. Endosc. 2005, 61, 76-79.
25. Khalid, A.; Nodit, L.; Zahid, M.; Bauer, K.; Brody, D.; Finkelstein, S.D.; McGrath, K.M. Ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am. J. Gastroenterol. 2006, 101, 2493-2500.
26. Maluf-Filho, F.; Kumar, A.; Gerhardt, R.; Kubrusly, M.; Sakai, P.; Hondo, F.; Matuguma, S.E.; Artifon, E.; Monteiro da Cunha, J.E.; Caesar Machado, M.C.; Ishioka, S.; Forero, E. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass. J. Clin. Gastroenterol. 2007, 41, 906-910.
27. Salek, C.; Benasova, L.; Zavoral, M.; Nosek, V.; Kasperova, L.; Ryska, M.; Strnad, R.; Traboulsi, E.; Minarik, M. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 1 8q in EUS-guided fine needle aspiration samples pf patients with chronic pancreatitis and pancreatic cancer. World J. Gastroenterol. 2007, 13, 3714-3720.
28. Fasanella, K.E.; Krasinska, A. Schoedel, K.E.; Sasatomi, E.; Slivka, A.; Whitcomb, D.C.; Sanders, M.; Nodit, L.; Raab, S.; McGrath, K.M.; Ohori, N.P.; Khalid, A. DNA mutational differences in cytological specimens from pancreatic cancer and cholangiocarcinoma. Pancreatology 2010, 10, 429-433.
29. Iacobuzio-Donahue, C.A.; Maitra, A.; Olsen, M.; Lowe, A.W.; van Heek, N.T.; Rosty, C.; Walter, K.; Sato, N.; Parker, A.; Ashfaq, R.; Jaffee, E.; Ryu, B.; Jones, J.; Eshleman, J.R.; Yeo, C.J.; Cameron, J.L.; Kern, S.E.; Hruban, R.H.; Brown, P.O.; Goggins, M. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 2003, 162, 1151-1162.
30. Crnogorac-Jurcevic, T.; Efthimiou, E.; Nielsen, T.; Loader, J.; Terris, B.; Stamp, G.; Baron, A.; Scarpa, A.; Lemoine, N.R. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 2002, 21, 4587-4594.
31. Logsdon, C.D.; Simeone, D.M.; Binkley, C.; Arumugam, T.; Greenson, J.K.; Giordano, T.J.; Misek, D.E.; Kuick, R.; Hanash, S. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003, 63, 2649-2657.
32. Laurell, H.; Bouisson, M.; Berthelemy, P.; Rochaix, P.; Dejean, S.; Besse, P.; Susini, C.; Pradayrol, L.; Vaysse, N.; Buscail, L. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J. Gastroenterol. 2006, 12, 3344-3351.
33. Pellise, M.; Castells, A.; Gines, A.; Agrelo, R.; Sole, M.; Castellvi-Bel, S.; Fernandez-Esparrach, G.; Llach, J.; Esteller, M.; Bordas, J.M.; Pique, J.M. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography-guided fine-needle aspiration biopsy. Clin. Cancer Res. 2004, 10, 4444-4449.
34. Crnogorac-Jurcevic, T.; Efthimiou, E.; Capelli, P.; Blaveri, E.; Baron, A.; Terris, B.; Jones, M.; Tyson, K.; Bassi, C.; Scarpa, A.; Lemoine, N.R. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001, 20, 7437-7446.
35. Steg, A.; Vickers, S.M.; Eloubeidi, M.; Wang, W.; Eltoum, I.A.; Grizzle, W.E.; Saif, M.W.; Lobuglio, A.F.; Frost, A.R.; Johnson, M.R. Hedgehog pathway expression in heterogeneous pancreatic adenocarcinoma: Implications for the molecular analysis of clinically available biopsies. Diagn. Mol. Pathol. 2007, 16, 229-237.
36. Fujita, H.; Ohuchida, K.; Mizumoto, K.; Itaba, S.; Ito, T.; Nakata, K.; Yu, J.; Kayashima, T.; Souzaki, R.; Tajiri, T.; Manabe, T.; Ohtsuka, T.; Tanaka, M. Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia 2010, 12, 807-817.
37. Kitoh, H.; Ryozawa, S.; Harada, T.; Kondoh, S.; Furuya, T.; Kawauchi, S.; Oga, A.; Okita, K.; Sasaki, K. Comparative genomic hybridization analysis for pancreatic cancer specimens obtained by endoscopic ultrasonography-guided fine-needle aspiration. J. Gastroenterol. 2005, 40, 511-517.
38. Franko, J.; Krasinskas, A.M.; Nikiforova, M.N.; Zarnescu, N.O.; Lee, K.K.; Hughes, S.J.; Bartlett, D.L.; Zeh, H.J., 3rd; Moser, A.J. Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma. J. Gastrointest. Surg. 2008, 12, 1664-1673.
39. Lee, J.; Jang, K.T.; Ki, C.S.; Lim, T.; Park, Y.S.; Lim, H.Y.; Choi, D.W.; Kang, W.K.; Park, K.; Park, J.O. Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma. Cancer 2007, 109, 1561-1568.
40. Torrisani, J.; Bournet, B.; Chalret du Rieu, M.; Bouisson, M.; Souque, A.; Escourrou, J.; Buscail, L.; Cordelier, P. Let-7 microRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum. Gen. Ther. 2009, 20, 831-844.
41. Hanoun, N.; Delpu, Y.; Suriawinata, A.A.; Bournet, B.; Bureau, C.; Selves, J.; Tsongalis, G.J.; Dufresne, M.; Buscail, L.; Cordelier, P.; Torrisani, J. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin. Chem. 2010, 56, 1107-1118.
42. Szafranska, A.E.; Davison, T.S.; John, J.; Cannon, T.; Sipos, B.; Maghnouj, A.; Labourier, E.; Hahn, S.A. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26, 4442-4452.